Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/19/2005WO2001098480A8 Promoters for regulation of plant gene expression
05/19/2005US20050108793 Auxin-inducible gene, ARGOS, that is involved in organ development, including size control, in plants; transgenic plants
05/19/2005US20050108792 Plastid transformation vector comprising anthrax protective antigen for use in generation of edible vaccines for conferring immunity to mammal against bacillus anthracis
05/19/2005US20050108791 Transgenic plants with improved phenotypes
05/19/2005US20050108790 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
05/19/2005US20050108788 Genes participating in the synthesis of fatty acid having trans-11-,cis-13-conjugated double bond and utilization thereof
05/19/2005US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders
05/19/2005US20050108783 Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region
05/19/2005US20050108782 Transgenic RS1-/- animal and uses thereof
05/19/2005US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/19/2005US20050107598 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107593 Flax protein isolate and production
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107591 Cysteine variants of erythropoietin
05/19/2005US20050107590 Mutated constitutively active nuclear ophan receptor
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107588 Membrane protein for use in diagnosis, treatment and prevention of infection, cell proliferative, autoimmune/inflammatory, nervous systeml, metabolic, developmental, endocrine, cardiovascular, reproductive, gastrointestinal, metabolic and lipid metabolism disorders
05/19/2005US20050107587 Hdv nucleic acid molecules fragments and applications thereof
05/19/2005US20050107586 Lp354 Mammalian secreted protein
05/19/2005US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors
05/19/2005US20050107584 Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome
05/19/2005US20050107581 Steam stripping beads under vacuum; divinyl benzene/ethyl vinyl benzene copolymers; dilution; for production of cephalosporin C and insulin
05/19/2005US20050107327 Administration of an NPY receptor antagonist to decrease the expression of the NPY gene; control cholesterol, LDL cholesterol and triglyserides in blood, prevent development of atherosclerosis
05/19/2005US20050107321 FLK-1 is a receptor for vascular endothelial growth factor
05/19/2005US20050107315 Mammary-associated serum amuloid a3 promoter sequences and used for same
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107313 Tumour suppressor gene
05/19/2005US20050107301 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation
05/19/2005US20050107299 Assays for novel serotonin transporter (SERT) blockers
05/19/2005US20050107297 Novel poly(ethylene glycol) modified compounds and uses thereof
05/19/2005US20050107296 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/19/2005US20050107295 Novel protein capable of inhibiting anthrax toxin activity
05/19/2005US20050107294 in an injectable form and to be administered through infiltrations inside and around cutaneous chronic ischemic ulcerative wounds as to prevent diabetic limb amputation
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107292 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
05/19/2005US20050106733 Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome
05/19/2005US20050106727 Peptides for enhanced cell attachment and growth
05/19/2005US20050106722 Efficient production of IgA in recombinant mammalian cells
05/19/2005US20050106701 Methods for the purification of defensins
05/19/2005US20050106700 Using immobilized cohesin domains as affinity tools in recovery of dockerin polypeptides
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106683 Antibodies specific for sclerostin and methods for increasing bone mineralization
05/19/2005US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
05/19/2005US20050106681 Enhanced solubility of recombinant proteins
05/19/2005US20050106680 Interferon-like protein Zcyto21
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106678 Human circulating cytokine CC-1
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106673 Mammalian receptor proteins; related reagents and methods
05/19/2005US20050106672 Neurotransmission associated proteins
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106669 Specific polynucleotides encoding them, as well as expression vectors and host cells; used for identifying compounds that inhibit an interaction between a Glutamate Transporter Associated Protein and a glutamate transporter protein, and for treating disorders associated with glutamate transport.
05/19/2005US20050106667 Variant complementary determining regions for use in identifying antigen binding polypeptides; mimetics; direceted protein evolution
05/19/2005US20050106666 Glial mitogenic factors, their preparation and use
05/19/2005US20050106663 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide
05/19/2005US20050106662 Novel food grade lantibiotic from streptococcus macedonicus and uses thereof
05/19/2005US20050106661 Fluorescent protein
05/19/2005US20050106660 Subjecting apoliprotein to mutagenesis at sequence positions 34 to 38 and other positions and muteins of aliproteins
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106653 Method for the identification of IRS protein kinase inhibitors or agonist
05/19/2005US20050106648 Immmunoglobulin specific to staphylococcal surface protein for use in diagnosis and prevention of bacterial infection; vaccine development; immunotherapy
05/19/2005US20050106643 Using intracellular protein which are expressed in a hormonally dependent manner as diagnostic indicator of cell proliferative disorders of breast and prostate
05/19/2005US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents
05/19/2005US20050106630 Building blocks for artificial receptors
05/19/2005US20050106629 Nanofabrication using actin filaments
05/19/2005US20050106628 MEGSIN protein
05/19/2005US20050106626 Resin immobilized peptide sequences for use as tool in diagnosis and prevention of alzheimer's disease; peptide mimetics
05/19/2005US20050106624 Concentrating low molecular weight peptides in the supernatant of serum-free cultured cells via cation exchangers; identifying tumor marker peptides and diagnosing cell proliferative disorders
05/19/2005US20050106623 Modified G-protein coupled receptors
05/19/2005US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders
05/19/2005US20050106616 DLC-1 gene deleted in cancers
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106603 G-protein coupled receptor having eicosanoid as ligand and gene thereof
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106600 Immunoglobulin for use in diagnosis, prevention, and treatment of tumor progression in cells; immunodiagnostic and therapeutics
05/19/2005US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping
05/19/2005US20050106598 Enhanced cellular uptake
05/19/2005US20050106597 Nucleotide sequences coding bacterial polypeptides for use in generating antibodies to prevent and treat staphylococcal infection
05/19/2005US20050106595 Expressed sequence tags and encoded human proteins
05/19/2005US20050106579 Regulated angiogenesis genes and polypeptides
05/19/2005US20050106571 Homodimeric taste receptor for use in identifying modulator of taste; food processing and flavors
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106565 Hybrid nucleic acids, ant antibodies thereof; insecticide
05/19/2005US20050106563 Severe acute respiratory syndrome (SARS) coronaviral polypeptide for use in diagnosis, prevention and treatment of viral disease; viricides; genetic vaccines
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106222 Genetic engineering; gene expression; polypeptides
05/19/2005US20050106185 Vaccines comprising acapsular P. multocida hyaE deletion mutants
05/19/2005US20050106184 Genetic engineered mutants lipid
05/19/2005US20050106180 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
05/19/2005US20050106179 Isolated complexes of endotoxin and MD-2
05/19/2005US20050106177 Stabilized by introducing trimeric motifs, preferably GCN4 coiled coil or fibritin trimeric domain at certain sites, for example in gp41 ectodomain; trimers or DNA molecules encoding such trimers can be used to generate immunogenic reactions
05/19/2005US20050106175 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages
05/19/2005US20050106164 Recombinant expression of heterologous nucleic acids in protozoa
05/19/2005US20050106162 Immunisation against chlamydia trachomatis